Matthew Herper covers medical innovation — both its promise and its perils. Everything changed with a white envelope. On Dec. 20, 2018, Jacob Van Naarden, the chief operating officer of a biotech ...

Eli Lilly’s LLY-2.09%decrease; red down pointing triangle experimental weight-loss drug retatrutide met the primary and key secondary endpoints in a trial, showing significant improvements in weight ...

With shares up 20% over the past 12 months, Eli Lilly appears to have come out on top in the battle to dominate the weight-loss drug market, with rival Novo Nordisk sinking 52% over the same period.

Eli Lilly scored $408 million in U.S. sales of eczema treatment Ebglyss in its first full year on the market in 2025. Now, with positive results from a phase 3 trial of the IL-13 inhibitor, the ...

This is read by an automated voice. Please report any issues or inconsistencies here. “Southern Hospitality” star Grace Lilly was arrested Tuesday in South Carolina on suspicion of drug possession ...

Southern Hospitality star Grace Lilly was arrested on a drug possession charge on Tuesday, March 10. Online court records viewed by Us Weekly show that Lilly, 27, was booked in Charleston County, ...

Add Yahoo as a preferred source to see more of our stories on Google. Eli Lilly has warned of high levels of an impurity in certain compounded versions of its blockbuster glucagon-like peptide-1 ...

Eli Lilly & Co will invest $3 billion in China over the next decade to expand local production, with a focus on weight loss as the US drugmaker looks to cement its dominance in the booming obesity ...

Hims & Hers Health (HIMS) has made a major change in its PR function with the hiring of Kathryn Beiser, who has served Lilly (LLY) as the weight loss drugmaker’s chief communications officer for five ...

Less than a week after Roche pledged a hefty investment in the South Korean biopharma industry, Eli Lilly is following suit with a $500 million, five-year pact of its own. Like Roche, Lilly has signed ...

Eli Lilly (LLY) announced on Thursday the launch of the Employer Connect platform, which enables employees to access its obesity therapy Zepbound at a lower cost through a network of pharmacies and a ...

Eli Lilly has officially launched Employer Connect, its direct-to-employer platform for its obesity medications, after teasing the rollout late last year. The drugmaker said in an announcement that ...